Lung cancer in Brazil
- PMID: 29538545
- PMCID: PMC6104542
- DOI: 10.1590/S1806-37562017000000135
Lung cancer in Brazil
Abstract
Lung cancer is one of the most incident types of cancer and a leading cause of cancer mortality in Brazil. We reviewed the current status of lung cancer by searching relevant data on prevention, diagnosis, and treatment in the country. This review highlights several issues that need to be addressed, including smoking control, patient lack of awareness, late diagnosis, and disparities in the access to cancer health care facilities in Brazil. We propose strategies to help overcome these limitations and challenge health care providers, as well as the society and governmental representatives, to work together and to take a step forward in fighting lung cancer.
O câncer de pulmão é um dos tipos de câncer com maior incidência e uma das principais causas de mortalidade por câncer no Brasil. Revisamos a situação atual do câncer de pulmão por meio de pesquisa de dados relevantes a respeito de prevenção, diagnóstico e tratamento no país. Esta revisão mostra várias questões que precisam de atenção, tais como controle do tabagismo, educação dos pacientes, desconhecimento por parte dos pacientes, diagnóstico tardio e desigualdade de acesso ao tratamento de câncer no Brasil. Propomos estratégias para ajudar a superar essas limitações e desafiamos os profissionais de saúde, a sociedade e os representantes do governo a trabalhar em conjunto e dar um passo à frente na luta contra o câncer de pulmão.
Figures



Similar articles
-
Smoking, mortality, access to diagnosis, and treatment of lung cancer in Brazil.Rev Saude Publica. 2024 May 13;58:18. doi: 10.11606/s1518-8787.2024058005704. eCollection 2024. Rev Saude Publica. 2024. PMID: 38747866 Free PMC article.
-
The barriers to initiating lung cancer care in low-and middle-income countries.Pan Afr Med J. 2020 Feb 12;35:38. doi: 10.11604/pamj.2020.35.38.17333. eCollection 2020. Pan Afr Med J. 2020. PMID: 32499854 Free PMC article. Review.
-
Impact of the delay to start treatment in patients with lung cancer treated in a densely populated area of Brazil.Clinics (Sao Paulo). 2017 Nov;72(11):675-680. doi: 10.6061/clinics/2017(11)05. Clinics (Sao Paulo). 2017. PMID: 29236913 Free PMC article.
-
[An interdisciplinary malignancy, the lung cancer in Hungary in 2006: epidemiology, prevention and access to therapy].Magy Onkol. 2006;50(3):207, 209-11, 213-5. Epub 2006 Nov 12. Magy Onkol. 2006. PMID: 17099779 Review. Hungarian.
-
Consensus study on the health system and patient-related barriers for lung cancer management in South Africa.PLoS One. 2021 Feb 11;16(2):e0246716. doi: 10.1371/journal.pone.0246716. eCollection 2021. PLoS One. 2021. PMID: 33571312 Free PMC article.
Cited by
-
The role of the surgeon in treating patients with lung cancer. An updating article.Sao Paulo Med J. 2021 May 28;139(3):293-300. doi: 10.1590/1516-3180.2020.0763.16022021. eCollection 2021. Sao Paulo Med J. 2021. PMID: 34076231 Free PMC article.
-
Implementation of an Integrated Lung Cancer Prevention and Screening Program Using a Mobile Computed Tomography (CT) Unit in Brazil.Cancer Control. 2022 Jan-Dec;29:10732748221121385. doi: 10.1177/10732748221121385. Cancer Control. 2022. PMID: 36204992 Free PMC article.
-
Can predictive factors determine the time to treatment initiation for oral and oropharyngeal cancer? A classification and regression tree analysis.PLoS One. 2024 Apr 17;19(4):e0302370. doi: 10.1371/journal.pone.0302370. eCollection 2024. PLoS One. 2024. PMID: 38630775 Free PMC article.
-
Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions.Front Oncol. 2022 Nov 14;12:1042766. doi: 10.3389/fonc.2022.1042766. eCollection 2022. Front Oncol. 2022. PMID: 36452484 Free PMC article.
-
Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer.J Cancer Res Clin Oncol. 2023 Dec;149(19):17651-17661. doi: 10.1007/s00432-023-05437-z. Epub 2023 Oct 16. J Cancer Res Clin Oncol. 2023. PMID: 37843557 Free PMC article. Review.
References
-
- World Health Organization . International Agency for Research on Cancer (IARC) Lyon: IARC; 2016.
-
- GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
-
- Brasil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva . Estimativa 2016: Incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2015. http/inca.gov.br
-
- Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet. 2015;385(9972):977–1010. doi: 10.1016/S0140-6736(14)62038-9. - DOI - PMC - PubMed
-
- Brasil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva . Estatísticas do Câncer: Mortalidade. Rio de Janeiro: INCA; http://inca.gov.br/vigilancia/mortalidade.asp
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical